Eli Lilly (LLY) wins FDA approval for its Alzheimer's disease drug, Kisunla. (donanemab). Sanofi (SNY) and Regeneron's Dupixent gets approval for COPD...

Lilly (LLY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Globe Life (GL) stands to gain from solid performance in its Life Insurance and Health Insurance segments, strong liquidity position and favorable...

A diversified tenant base, accretive buyouts and solid balance sheet strength bode well for Realty Income (O). The steady rise in the monthly dividend...

MGIC Investment (MTG) is well-poised to gain from solid insurance in force, a decline in loss and claims payments, better housing market fundamentals...

Eli Lilly (LLY) files for the approval of tirzepatide to treat obstructive sleep apnea in adults with obesity in the United States. If approved, sales...

Radian Group (RDN) stands to gain from strong persistency rates, improved new insurance written, a strong capital position, favorable growth estimates...

Paycom (PAYC) is well-poised to grow on the back of strong revenues, robust cash flows and its diverse portfolio serving the breadths of the human...

Ensign Group (ENSG) remains well-poised for growth on the back of solid segmental contributions, an expanding healthcare portfolio and sound cash...

Ensign Group (ENSG) remains well-poised for growth on the back of solid segmental contributions, an expanding healthcare portfolio and sound cash...